# Salesforce to Buy Marketing Platform Braze for $5.7 Billion

> **Open Intelligence Dossier** · First detected: 2026-10-20 15:40 UTC · Category: Business

## Executive Summary
Major corporate acquisitions drive business coverage as Salesforce moves on Braze and EQT targets Qiagen.

## Intelligence Brief
Recent financial reporting from outlets including Bloomberg, Reuters, the Financial Times, and Yahoo Finance documents two major corporate takeover agreements. Salesforce is moving to acquire the marketing platform Braze in a deal valued at approximately $5.7 billion, or $5.66 billion depending on the report, designed to strengthen AI-led customer engagement and the customer experience push. Concurrently, Sweden&amp;#039;s EQT Private Equity has reached a recommended voluntary all-cash public takeover agreement to acquire the German diagnostics and molecular testing firm Qiagen, taking the tools provider private in a transaction valued variously at $12.1 billion, $10.8 billion, or €10.8 billion, following earlier advanced talks and a prior COVID-era bid that had been derailed by Davidson Kempner. Coverage of these developments emphasizes the scale of the transactions and their ripple effects across respective markets, with heavy tracking from Business Wire, Marketscreener, GenomeWeb, Genetic Engineering and Biotechnology News, and BioXconomy.


Regarding the Qiagen deal, financial institutions and analysts have adjusted their positions accordingly; Berenberg lifted its target to EQT&amp;#039;s €46.50 bid, Bank of America assigned no rating to Qiagen amid the buyout, and Benzinga noted that the long-awaited buyout closed at a 15x EBITDA multiple as slow growth curbs pricing. Meanwhile, Salesforce&amp;#039;s acquisition of Braze prompted shifts in analyst sentiment, with TD Cowen downgrading Braze stock to a hold rating while Jefferies suggested the CRM deal could spark further software takeovers, and Yahoo Finance reported that BRZE, HLT, and HAS stocks hit 52-week highs. Context provided within the coverage notes that the Qiagen take-private transaction follows a previous pandemic-era buyout attempt that failed when it was derailed by Davidson Kempner, while German stocks retreated generally as Qiagen shares rose on the proposed EQT buyout. For Salesforce, the Braze purchase represents a strategic expansion into AI-led customer engagement and customer experience enhancement.


Coverage does not yet specify the final closing dates for either transaction, nor does it detail regulatory approval timelines beyond the initial announcements made by the involved corporations and reported by international financial news agencies. Observers and market participants are monitoring how these multi-billion-dollar deals will progress through regulatory review and shareholder approvals. Financial coverage highlights the specific valuation metrics for Qiagen, including the EBITDA multiple and the exact bid figures in Euros and US dollars, alongside the broader market implications for software sector consolidation following the Salesforce agreement. Coverage does not yet detail the operational integration plans for either Qiagen under EQT private ownership or Braze under Salesforce, leaving subsequent developments subject to future corporate disclosures and regulatory filings.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Genetic Engineering and Biotechnology News | EQT to Acquire Qiagen for $12.1B, Plans to Take Tools, Diagnostics Provider Private | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxORE51N0EzdGxYYXVoYVh2ZjNfamhtRlcwZ2g2QXRZem9tU3AxMWk3ZVFrTXlVbGlPcm96WTZMUmFJSUo1VEd2TXpHT0hSZ1VKc3cyWTI5dW9zREhPR0FQd3J5b1kwMmVzWGJScnlpRTRkTTVWNU94bWl5UklYc3AxMDNBdnE0TXJONmlEblJRb2ROVFRBUXpnS0lBY0xYUE02bEdRdEw5X1JIdG5aNUtKM3pqSExxUl8yM2E5N0hMQVZvX2xwbXVPcA?oc=5) |
| BioXconomy | Qiagen set for private ownership as EQT proposes $10.8bn takeover deal | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxNR005ZEFVQzhtb053dnhhRnJVT29PNk8wNXMxS0NnMFFPZldQX2t1SjZuYloyZXY3S05GY0pUZGRFcXhHbVNENXBYd2FMZGVUai1odTZ1UmxWQ1B3dVZEcXowOW5UemZDRG9QRGtCblRlbGRGeXBnZ2U4ZW00d1BtQkxIZHpVT3B2UktnTlF3OHZ3X2VUNkkxUmk4SWxlMUZUd0VJOHJUeDBncTg?oc=5) |
| marketscreener.com | German Stocks Retreat; Qiagen Rises on Proposed Buyout by EQT | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxQYndKZkVlTGU3b3FOc0JKNDdvRDdTcENTc2g0RzhYa3Y1cDZ4S1BQTTBUYlNCM2dhN0hVeUY0dTNTX1oydktaOU01cndfeTNIaHRGUXZlV3lnU09aWTVXdnBVT3EtTDcteGtJVzV5aEgxbGRlaTVIQzNDekFLRjFMckgyMW11YkxrbXRHT1RqS2NURXE5Zi02SHFfSEhfM190akVYeldLcFpaZlBEdnRLc01TSQ?oc=5) |
| Benzinga | Long-Awaited Qiagen Buyout Closes At 15x EBITDA Multiple as Slow Growth Curbs Pricing | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxQc0pYMnNiNzhkVC0yem1DVW9KamdxckxpX05BRndMdVFkRDFHZ3FSalUyVmczbl9NYWUxX3VndjBXY0hMeTFBcjZIT1BQdzZrcVd0Y2VibGc2U3g2dlEycFR3ZTV6N0ppVXVRN3NEcGdpWlE0NmlPeU56d2xHQ3BZVmdReGg2NTFjUlNBS3pIZmZDbUhxNUx3TFJJeUd5czMwTFhKTC1NNng4YnNvTkc0MXFTZ21fWjdEY3o1Mmkzd2tyUTh4aFQzcA?oc=5) |
| Finimize | Berenberg Lifts Qiagen Target To EQT’s €46.50 Bid | [Source Link](https://news.google.com/rss/articles/CBMigAFBVV95cUxONnN4SkhhSGVQUHN3V2ljUzAtUXFsLW9TcGdZaUdkTkxNQmFhYUZBeFVIbEozVkltMlduU2hWT3IyOWpnYnVvVWFFc3FZT1lFWE5rMEY0YU5ZazVnc3ZwTnFWMFR0V0lEYU9Pc084dFJlQ3VzQ0sydmo3aTZxREloMg?oc=5) |
| GenomeWeb | Qiagen Going Private as Sweden’s EQT to Buy Firm for $10.8B | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxPTDgzMnI5UVhYU0pDVWpqdDlyR1Q1Mjk0YVFIVjRnVi0wVHp1Vk14WVJ1SUktUHBMNnh3WnBTOHFScDZ4UG5LUk5PMVRwdy1ScTV5UHlmZmJmUmZfclF1MUtjQUxLZFZ1NlFKMzhHOVNFUUduRkFtdmVDTVEySVRrSXVaamZqZXVPaU1uTUU5QzJYRldHX0Q4ZHN5SnBnTEJORVhldzBPTktkSThWSkEwZTJjcTZyc2tzOEpRSjd6MmUxMVgyNmxpNXBZU25UdnVwSFBn?oc=5) |
| GuruFocus | Bank of America Assigns No Rating to Qiagen (QGEN) Amid EQT Buyo | [Source Link](https://news.google.com/rss/articles/CBMitwFBVV95cUxNYkpVUU92MnQ1a2RUUDk4T0V6N1VNQk1EZzVESHAyeF9EMXlwNnd3bTBfaHh5NENpU3htX1JocjR5WlI2dkxibVB4MGVmc1RPbFBFcHFmUXRUVzQtQkdvbDU0cVJLU2x0b2d4UnhUVGM1dGx2ci16QWp0MmdidE9vSlpFcHVTbjk3c2hCVFpuOUF5M0x1Ni04SVdLMC1SZV9ERlVYOGVhR3gxR2pOejRXZXp0V29iVkE?oc=5) |
| Bloomberg.com | EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxQY2h3aUlzSVhKcy10N0RHVjV6NWUwdXV1ajJLTHhNeG5ULVlWdERFNVhuaFdQX3pXWGhySE5SbWxHbTlIcUJUanBMUzZsak5kT3Z0ZXQteEFRQktfblBNOGtaeGF1RTFHSFJNVVd0UDFEaHh1M2E2bXdDN01OcmMtR3JZLVVDck5SU1lVTHI2UDBvNEFYTVpDRzNsWTYzOU5ib3NxMURRb1BaQUJwT2pmYw?oc=5) |
| marketscreener.com | Qiagen Agrees to EUR10.8 Billion Takeover by EQT | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxNWEhSZVJ1NnFsd2NRM2Z0MEdYTnlmalNmU3hwejhTNENrWXRKV1N3OEE4R0k4VExzYzhUdHpaZ19SN1duSXlFMFdJbU5aSnVvb3RfRUJ1eE5PT2QzM1JUOFpVaVVFSldRSXZqcm5BOHZaQXJ5RkdYUVk3NFYxVVZEZE1Iajc2R2tOc04tdlBsNC12SHFDVFJlMkVLNngtenZxaVU4?oc=5) |
| Alternatives Watch | EQT’s €10.8bn Qiagen take-private follows COVID-era bid derailed by Davidson Kempner | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxNaU5rMFlfX3ZpaFJjUTh2bkdOMWtiSU10cDhLZEdJUWRkS3J5ZkRkdzhvSXp5Y0Q1ZFF6dFF4bVpaUXprVnJrcHdPWk55Ynh3c2FmT2ttQk5aNHZLRnlyZWRRNS1DZWFKeXdWeXAtN3YtSW1aQWZTZ2RDcU5jRnFiZDg4Y29BOUFsRGNtT2U0UXlpcEVwc3BkVF9KUk9peHhkSnc?oc=5) |
| Business Wire | QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer | [Source Link](https://news.google.com/rss/articles/CBMi9gFBVV95cUxPSW85Znh5SVc5c195OEdmVlZEUnJiNEdFMnh0dFNwOGlUb1phclFaaFVrcWZLbDlad3J0NGJlTTV5dFEtcDBNVlZadGJIcXcwMnVMZWQ1R21rMEk2OFo5VG9wWDJxVWMxSkJ4WVhmb1ZPdjFadVFOampPbkJWVklYVmRpUTF1M1N5LXVOOGlyZEppMlU4bXFua2d4VGI2Z1Q4dVZkRUpVQVhkVUoxajhHSFQybTNWMjlQRXJLVXJaekVPVWVaNGZxQ09iLXB2MG9LQUNRekVGNmFIQkx3NVM0aXFqMzFsVWwwVEdNRldHR25HWXF1THc?oc=5) |
| Bloomberg.com | EQT Is in Advanced Talks to Buy Testing Firm Qiagen | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxNNnlYSV9qcTdtYmZCTVk2b2xzeGFmYU5QbTVpT1FsTFo3SEhQNnlCdkRvZFZNR1R3SHVTNGIzY2JGM0hwSVZ4b2M3b1hFNzdlaTQwdzBYVjlaWlNkeXVuWG9DMjJSaDhLMkpEeTl6azJzWFk2Rkt1VjQ0azF2X0x2QTJTa1pKeVNWYkw5XzJFYm1oMVRWV3RheHNWMEdyYWFIY2Z4VA?oc=5) |
| Financial Times | Buyout firm EQT acquires German diagnostics group in €10.8bn deal | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxNQ0V5c0drczRaMkl4eThiVl9USGU2Umd1a0Z4aXk1TDczbVM0a3BmQXkzYjAzeXozMGtaN2NqaGhORzlYaUZmaW4xTkNuNlJSUmx5ZEZlNE9WeGZRX2FWM2xDSFVnWEdhU3VKVDM3NG5zY1dNNWxFY2dlSjlYdk44NnZTc18?oc=5) |
| Reuters | EQT to buy molecular testing firm Qiagen for $10.8 billion | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxNVHkyNW5pTXVNT2J0VFpZaGVHcW95Q3lkRWZ0clJYMVdva0M4b3BDUkwzQkNnRk41T2x3M1E1bDlxUUlCYTI5cVFHc093UU5rYndOcGRpa2FjSHBreml6WGJrbHFBSXhmaTB3QUozeDVQRERJMkhpTDFCUy1zZHk0aWIxcEhpdnJjTUd3bERiNmZleEM1enEyQlpuUDNYekE?oc=5) |
| ET BrandEquity | Salesforce to acquire Braze for $5.66 billion to strengthen AI-led customer engagement | [Source Link](https://news.google.com/rss/articles/CBMi7gFBVV95cUxQcWJuSVZndzlyU1g5S1Nmd1dObnpSNTN5Y1YtY2VjaHZJRXE4VTBDQm03bjl4ZVZPM1p2VHA2TkRaS1NPOW91NjdNSlJNWlpDUTlfeldiVE9UaXBMb2xfcXFRaWxDdnJvN2Z2SmtsRFlUTjdsUHVfYno5aU5qbElXNVV1MEpoT25OWGxaU2lDQkZpU3FVTHpMc1BwcHJxNHpGQVV6aFhPbmxkM1I3Mk41UlE1STVGODl0VndfblZtekN3NXJERlM5ckVNOVJXRzk1dFFjLTBiZ3VmMXk4SUJDMTd3VjdDemFjYXY2cXFn0gHzAUFVX3lxTE04Y052aTBjbElwSWlGUzVabFFFWmlsZVMtU2Q2OEphU2Z6Y2VGamVTSTVWZUtzd3ZWV0dySExRXzBLRXJvb1ZrZTZaWGFCRElkcGRpdnVhMmpVdzlUeVNnNWl4djN) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-20/salesforce-to-buy-marketing-platform-braze-for-5-7-billion*
